Physicians' Academy for Cardiovascular Education

ACC.19

PACE-CME.org was present at ACC Scientific Sessions 2019 in New Orleans, LA, USA. Find coverage of the latest CV news on PACE-CME.

Detection of AF with wearable technology to prevent stroke

3' education - Apr. 8, 2019

Improved QoL with transcatheter mitral valve repair in HF patients with secondary mitral regurgitation

3' education - Apr. 8, 2019

Centrifugal-flow pump superior to axial-flow pump for clinical outcomes in advanced HF

3' education - Apr. 8, 2019

No difference in survival with immediate vs. delayed coronary angiography after cardiac arrest in NSTEMI patients

3' education - Apr. 8, 2019 - Jorrit Lemkes

Clinical benefit with SGLT2 inhibitor in diabetes patients with HF independent of ejection fraction

3' education - Apr. 8, 2019 - Dr. Eri Kato, Kyoto, Japan

Device safely keeps HF patients out of the hospital

3' education - Mar. 17, 2019

Long-term data confirm safety and efficacy of oral antibiotics in left-sided endocarditis

3' education - Mar. 27, 2019

TAVR vs surgery in aortic stenosis: reason for a paradigm flip?

3' education - Mar. 19, 2019 - New Orleans, LA, USA - Janet Wyman

Highly purified omega-3 fatty acid not only lowers first ischemic events, but also recurrent events

3' education - Mar. 19, 2019 - Deepak L. Bhatt, MD

Benefits of early initiation of ARNI in acute HF confirmed in open-label extension study

3' education - Mar. 19, 2019 - Adam DeVore, MD

Cholesterol synthesis inhibitor has potential to be add-on therapy to statin in patients with high CV risk

3' education - Mar. 19, 2019 - Anne Carol Goldberg, MD

Substantial reduction in clinical outcomes with TAVR in aortic stenosis patients at low surgical risk

3' education - Mar. 19, 2019 - New Orleans, LA, USA - Martin B. Leon, MD

Better outcomes in patients with AF and ACS/PCI with NOAC vs. VKA and when dropping aspirin

3' education - Mar. 17, 2019 - New Orleans, LA, USA - John Alexander, MD

Proof-of-concept study shows 84% true AF in those with irregular pulse detected with smartwatch

3' education - Mar. 16, 2019 - New Orleans, LA, USA - Michael Valentine, MD

Lifestyle improvement forms foundation of comprehensive guideline for primary prevention

3' education - Mar. 16, 2019 - New Orleans, LA, USA - Dr. Amit Khera

New overarching recommendations in primary prevention guideline should help implementation of advise

3' education - Mar. 16, 2019 - New Orleans, LA, USA - Donna Arnett, MD

Detection of AF with wearable technology to prevent stroke

3' education - Apr. 8, 2019
Annabelle Volgman discusses the results of the Apple Heart Study. This trial examined whether wearable technology can be used to detect AF in asymptomatic individuals to prevent stroke.

ACC 2019Annabelle Volgman discusses the results of the Apple Heart Study. This trial examined whether wearable technology can be used to detect AF in asymptomatic individuals to prevent stroke.

Improved QoL with transcatheter mitral valve repair in HF patients with secondary mitral regurgitation

3' education - Apr. 8, 2019
Previous results have shown benefits in mortality and HF hospitalization with MitraClip. New data complement the previous findings and demonstrate improved quality of life with MitraClip in HF patients with secondary MR.

ACC 2019 Previous results have shown benefits in mortality and HF hospitalization with MitraClip. New data complement the previous findings and demonstrate improved quality of life with MitraClip in HF patients with secondary MR.

Centrifugal-flow pump superior to axial-flow pump for clinical outcomes in advanced HF

3' education - Apr. 8, 2019
In the MOMENTUM 3 trial, the centrifugal-flow pump HeartMate 3 was compared with the axial-flow pump HeartMate 2 in patients with advanced HF. Prof. Uriel discusses the findings and implications of this trial.

ACC 2019 In the MOMENTUM 3 trial, the centrifugal-flow pump HeartMate 3 was compared with the axial-flow pump HeartMate 2 in patients with advanced HF. Prof. Uriel discusses the findings and implications of this trial.

No difference in survival with immediate vs. delayed coronary angiography after cardiac arrest in NSTEMI patients

3' education - Apr. 8, 2019 - Jorrit Lemkes
The COACT trial examined whether NSTEMI patients had a better survival after cardiac arrest using immediate coronary angiography vs. delayed strategy.

ACC 2019 The COACT trial examined whether NSTEMI patients had a better survival after cardiac arrest using immediate coronary angiography vs. delayed strategy.

Clinical benefit with SGLT2 inhibitor in diabetes patients with HF independent of ejection fraction

3' education - Apr. 8, 2019 - Dr. Eri Kato, Kyoto, Japan
In diabetes patients, use of dapagliflozine resulted in clinical benefit regardless of ejection fraction and CV death and total mortality were strongly reduced in HFrEF patients.

ACC 2019 In diabetes patients, use of dapagliflozine resulted in clinical benefit regardless of ejection fraction and CV death and total mortality were strongly reduced in HFrEF patients.

Device safely keeps HF patients out of the hospital

3' education - Mar. 17, 2019
Pulmonary artery pressure-guided therapy in class III HF patients met the primary efficacy and two safety endpoints at 1 year in the CardioMEMS trial.

ACC 2019 Pulmonary artery pressure-guided therapy in class III HF patients met the primary efficacy and two safety endpoints at 1 year in the CardioMEMS trial.

Long-term data confirm safety and efficacy of oral antibiotics in left-sided endocarditis

3' education - Mar. 27, 2019
Previously, short-term results of the POET trial were presented. Now, long-term data confirmed that oral antibiotics are as safe and effective as IV treatment in patients with left-sided endocarditis.

ACC 2019 Previously, short-term results of the POET trial were presented. Now, long-term data confirmed that oral antibiotics are as safe and effective as IV treatment in patients with left-sided endocarditis.

Echocardiographic predictors of clinical outcomes in patients with HF and severe secondary mitral regurgitation

News - Mar. 21, 2019

ACC 2019 In an echocardiography substudy of the COAPT trial, predictors of poor outcomes were studied in HF patients with severe secondary mitral regurgitation.

Early in-hospital initiation of ARNI after ADHF improves outcomes in HFrEF

News - Mar. 21, 2019

ACC 2019 An open-label extension study of the PIONEER-HF trail showed that in-hospital initiation of sacubitril/valsartan (S/V) improved clinical outcomes after ADHF among HFrEF patients, compared to in-hospital initiation of enalapril followed by S/V.

Less brain damage with intensive BP-lowering in older hypertensives, but no functional improvement

News - Mar. 20, 2019

ACC 2019 The randomized INFINITY trial showed a significant reduction in accrual of subcortical white matter disease in older people receiving more intensive antihypertensive therapy, but mobility and cognitive function were not improved.

Pulmonary artery pressure-guided therapy reduced HHF and was safe in HF patients

News - Mar. 19, 2019

ACC 2019 Post-approval analyses of the CardioMEMS PAS trial showed that adapting therapy based on pulmonary artery pressure is effective in reducing hospitalizations for HF and safe in patients with NYHA class III HF.

Angiography timing does not affect survival after cardiac arrest in NSTEMI patients

News - Mar. 19, 2019

ACC 2019 The COACT trial did not show improved survival at 90 days with immediate vs. delayed coronary angiography in NSTEMI patients with return of spontaneous circulation after out-of-hospital cardiac arrest.